The purpose of the Week 5 Disease Process Assignment Part 2 is for learners to:
- Develop professional presentation/communication skills.
- Link development of initial presenting signs and symptoms of disease to changes to tissue, organ and system functioning.
- Describe how the disease is diagnosed
- Describe pharmacological and non-pharmacological interventions for disease management.
Due Date: Sunday 11:59 PM MT at the end of Week 5
- Analyze pathophysiological mechanisms associated with select disease states.
- Relate research findings to the management of patients with complex pathophysiologic dysfunction.
Total Points Possible: 100 points
Description of the Assignment
In Week 7, students will present an audio/video PowerPoint presentation using the Disease Process Presentation Guidelines and Rubric located under Course Resources. To ensure timely development of the Week 7 assignment and an opportunity to receive feedback from the course faculty, students will develop the Week 7 presentation in 2 parts. Parts 1 and 2 will be submitted as a PowerPoint presentation that contains thorough speaker notes. After students have received faculty feedback on Parts 1 and 2, students will develop the final presentation that is audio and video recorded and uploaded to the Week 7 Discussion Board.
Criteria for Content
- Link changes in the tissue, organ, and system functioning to the initial presenting signs and symptoms seen in primary careof the disease.
- Provide a brief description of how the disease is diagnosed.
- Provide a brief description of the pharmacological and non-pharmacological interventions used to treat and manage the disease.
- Summarizes the disease on final slide with concluding remarks; includes implication for nurse practitioner practice.
- Utilizes at least two current (within 5 years), peer-review scholarly sources to support presentation content.
- Reference slide and in-text citations depict references correctly cited according to APA.
Hypertension, commonly referred to as high blood pressure (BP) is a chronic elevation of rate of blood pressure which progressively causes end-organ damage and leads to increased morbidity and mortality (Leung et al., 2017). Hypertension is characterized by a systolic blood pressure (SBP) greater than or equal to 140 mm Hg or a diastolic blood pressure (DBP) greater than or equal to 90 mm Hg, or being under antihypertensive medication (Flack, Calhoun, & Schiffrin, 2017). According to Flack et al. (2017), the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) classifies BP for adults aged 18 years and above as follows:
Normal: SBP lower than 120 mm Hg, DBP lower than 80 mm Hg
Prehypertension: SBP 120-139 mm Hg, DBP 80-89 mm Hg
Stage 1: SBP 140-159 mm Hg, DBP 90-99 mm Hg
Stage 2: SBP ≥160 mm Hg, DBP ≤ 100 mm Hg…..Please click the icon below to purchase full solution at $10